Two Sigma Securities »

Atara Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 68k 0.51

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics